ATR and adenocarcinoma: The extent of ATR N-homocysteinylation, correlated with Hcy levels in HCT116 and A549 adenocarcinoma cells, reduces ATR activity by impairing the ATR-ATRIP interaction, which results in DNA damage in CRC.